ChengDa Pharmaceuticals Co. Ltd. Asset Resilience Ratio

Latest as of June 2026: 32.14%

ChengDa Pharmaceuticals Co. Ltd. asset resilience ratio. ChengDa Pharmaceuticals Co. Ltd. (301201) has an Asset Resilience Ratio of 32.14% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ChengDa Pharmaceuticals Co. Ltd. (301201) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥755.58 Million

≈ $110.56 Million USD Cash + Short-term Investments

Total Assets

CN¥2.35 Billion

≈ $343.98 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of ChengDa Pharmaceuticals Co. Ltd. (2022–2025)

Asset resilience ratio of ChengDa Pharmaceuticals Co. Ltd. from 2022 to 2025. This chart shows how ChengDa Pharmaceuticals Co. Ltd.'s Asset Resilience Ratio has changed over time. Read 301201 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down ChengDa Pharmaceuticals Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ChengDa Pharmaceuticals Co. Ltd. balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥755.58 Million	32.14%
Total Liquid Assets	CN¥755.58 Million	32.14%

Asset Resilience Insights

Very High Liquidity: ChengDa Pharmaceuticals Co. Ltd. maintains exceptional liquid asset reserves at 32.14% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

ChengDa Pharmaceuticals Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare ChengDa Pharmaceuticals Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

ChengDa Pharmaceuticals Co. Ltd. Asset Resilience Ratio by Year (2022–2025)

ChengDa Pharmaceuticals Co. Ltd. asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for ChengDa Pharmaceuticals Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.49%	CN¥270.08 Million ≈ $39.52 Million	CN¥2.35 Billion ≈ $343.86 Million	-27.81pp
2024-12-31	39.31%	CN¥957.65 Million ≈ $140.13 Million	CN¥2.44 Billion ≈ $356.53 Million	+5.85pp
2022-12-31	33.46%	CN¥776.89 Million ≈ $113.68 Million	CN¥2.32 Billion ≈ $339.77 Million	--

pp = percentage points

About ChengDa Pharmaceuticals Co. Ltd.

SHE:301201 China Drug Manufacturers - Specialty & Generic

Market Cap

$539.95 Million

CN¥3.69 Billion CNY

Market Cap Rank

#11527 Global

#3214 in China

Share Price

CN¥23.85

Change (1 day)

+6.38%

52-Week Range

CN¥22.42 - CN¥62.75

All Time High

CN¥86.94